| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574257 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 10 Pages |
Abstract
The efficacy and safety of edaravone combined with tPA and administered within 4.5 hours of AIS onset were demonstrated with numerically lower incidence of sICH and better outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Takenori MD, Hideto MS, Hiroaki MPH, Norio MD, PROTECT4.5 Investigators PROTECT4.5 Investigators,